schizandrin b has been researched along with Colitis Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Q; Chen, C; Chen, X; Chen, Z; Ding, D; Gao, X; He, L; Hu, K; Li, J; Lu, Y; Luo, Y; Qi, R; Quan, F; Sun, R; Tao, W; Wang, D; Yang, Y; Yang, Z; Zhao, D; Zhao, S | 1 |
1 other study(ies) available for schizandrin b and Colitis Gravis
| Article | Year |
|---|---|
Schisandrin B prevents ulcerative colitis and colitis-associated-cancer by activating focal adhesion kinase and influence on gut microbiota in an in vivo and in vitro model.
Topics: Animals; Caco-2 Cells; Colitis, Ulcerative; Colonic Neoplasms; Cyclooctanes; Cytoprotection; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Gastrointestinal Microbiome; HCT116 Cells; Humans; Intestinal Mucosa; Lignans; Male; Mice; Mice, Inbred C57BL; Permeability; Polycyclic Compounds; Signal Transduction | 2019 |